Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma-Reference-Cited by-同舟云学术

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Published:2019-07-25 Issue:4 Volume:381 Page:338-348
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Loriot Yohann¹,Necchi Andrea¹,Park Se Hoon¹,Garcia-Donas Jesus¹,Huddart Robert¹,Burgess Earle¹,Fleming Mark¹,Rezazadeh Arash¹,Mellado Begoña¹,Varlamov Sergey¹,Joshi Monika¹,Duran Ignacio¹,Tagawa Scott T.¹,Zakharia Yousef¹,Zhong Bob¹,Stuyckens Kim¹,Santiago-Walker Ademi¹,De Porre Peter¹,O’Hagan Anne¹,Avadhani Anjali¹,Siefker-Radtke Arlene O.¹

Affiliation:

1. From Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Université Paris-Saclay, Villejuif, France (Y.L.); Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (A.N.); Sungkyunkwan University Samsung Medical Center, Seoul, South Korea (S.H.P.); Genitourinary and Gynecological Cancer Unit, Centro Integral Oncológico Clara Campal, Madrid (J.G.-D.), Hospital Clinic Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona (B.M.), and Hospital Universitario Marques de...

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1817323

Cited by 863 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FOLLOW-U; study protocol evaluating oncological systemic treatment response of advanced bladder cancer patients using urinoids;2024-02-05

2. Identification of FGFR3 D641N rare variant in a case of primary lacrimal gland cancer;Medical Reports;2024-02

3. Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma;European Urology Oncology;2024-02

4. Emerging Therapies in Management of Cholangiocarcinoma;Cancers;2024-01-31

5. Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and Future Directions;Current Oncology;2024-01-29